Oxyquinoline

Oxyquinoline

SCHEMBL11030477

O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.Oc1cccc2cccnc12.Oc1cccc2cccnc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Oxyquinoline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 known ✓ P11229 1/20 0.81
ADRA1A known ✓ P35348 1/20 0.81
KDM4E B2RXH2 4/20 1.00
ALOX12 P18054 2/20 1.00
COMT P21964 3/20 0.81
MMP2 P08253 2/20 0.81
TSHR P16473 2/20 0.81
METAP2 P50579 1/20 0.81
METAP1 P53582 1/20 0.81
HDAC8 Q9BY41 1/20 0.81
LMNA P02545 3/20 0.63
ALDH1A1 P00352 3/20 0.63
MAPK1 P28482 2/20 0.58
CA1 P00915 1/20 0.58
CA2 P00918 1/20 0.58
CA9 Q16790 1/20 0.58
TDP1 Q9NUW8 3/20 0.55
GAA P10253 3/20 0.55
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxyquinoline SCHEMBL11030481 1.00 KDM4E (1.00) KDM4EALOX12COMTMMP2TSHR
Oxyquinoline SCHEMBL29358129 1.00 KDM4E (1.00) KDM4EALOX12COMTMMP2TSHR
Oxyquinoline SCHEMBL29390000 1.00 KDM4E (1.00) KDM4EALOX12COMTMMP2TSHR
Oxyquinoline SCHEMBL11030474 1.00 KDM4E (1.00) KDM4EALOX12COMTMMP2TSHR
Oxyquinoline SCHEMBL9625423 1.00 KDM4E (1.00) KDM4EALOX12COMTMMP2TSHR
Oxyquinoline SCHEMBL48928 1.00 KDM4E (1.00) KDM4EALOX12COMTMMP2TSHR
Oxyquinoline SCHEMBL29598375 1.00 KDM4E (1.00) KDM4EALOX12COMTMMP2TSHR
Oxyquinoline SCHEMBL324753 1.00 KDM4E (1.00) KDM4EALOX12COMTMMP2TSHR
Oxyquinoline SCHEMBL406261 1.00 KDM4E (1.00) KDM4EALOX12COMTMMP2TSHR
Oxyquinoline SCHEMBL6081972 0.98 KDM4E (0.96) KDM4EALOX12COMTMMP2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8557096-B2 Multistage method for treating metal surfaces prior to dip painting HENKEL AG & CO. KGAA (DE) 2013-10-15 US disclosed
US-20120186986-A1 MULTISTAGE METHOD FOR TREATING METAL SURFACES PRIOR TO DIP PAINTING HENKEL AG & CO. KGAA (DE) 2012-07-26 US disclosed